Showing 57,361 - 57,380 results of 226,405 for search '(( a ((((teer decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.96s Refine Results
  1. 57361

    A survey to determine effects of human interference on grassland and disturbed area herbaceous plants, vertebrates and invertebrates at York University by Justin Kim (3117231)

    Published 2016
    “…Only plants larger than 1.5m in height were counted. Having a height requirement decreased the probability of counting a non-woody plant. …”
  2. 57362

    Evolution from a single 20-year model simulation of a 5-year cycling strategy with DHA-PPQ used in the first five years, ASAQ in the following five years, AL during years 10-15, an... by Kien Trung Tran (12035464)

    Published 2025
    “…Triangles with dashed borders indicate that a genotype frequency is decreasing, and the dark gray triangles indicate that a genotype has disappeared. …”
  3. 57363

    WT mice (gray) display a greater increase in insulin resistance than <i>Dp(11)17/+</i> mice (red) after HF diet from 19 to 22 weeks as well as an increased weight gain after a long... by Melanie Lacaria (162331)

    Published 2012
    “…<p>(A) During IP-GTT, WT mice display more dramatically decreased glucose clearance rate (*p = 0.00011) after HF diet than <i>Dp(11)17/+</i> mice (*p = 0.03). …”
  4. 57364
  5. 57365

    Table_3_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…</p>Methods<p>We bring pioneering contributions on the maintenance of the immune response over a year on a real-life basis study in 1,587 individuals (18-90 yrs, median 39 yrs; 1,208 female/379 male) who underwent vaccination with two doses of CoronaVac and BNT162b2 booster after 6-months of primary protocol.…”
  6. 57366

    Table_2_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…</p>Methods<p>We bring pioneering contributions on the maintenance of the immune response over a year on a real-life basis study in 1,587 individuals (18-90 yrs, median 39 yrs; 1,208 female/379 male) who underwent vaccination with two doses of CoronaVac and BNT162b2 booster after 6-months of primary protocol.…”
  7. 57367

    Table_4_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…</p>Methods<p>We bring pioneering contributions on the maintenance of the immune response over a year on a real-life basis study in 1,587 individuals (18-90 yrs, median 39 yrs; 1,208 female/379 male) who underwent vaccination with two doses of CoronaVac and BNT162b2 booster after 6-months of primary protocol.…”
  8. 57368

    Table_1_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…</p>Methods<p>We bring pioneering contributions on the maintenance of the immune response over a year on a real-life basis study in 1,587 individuals (18-90 yrs, median 39 yrs; 1,208 female/379 male) who underwent vaccination with two doses of CoronaVac and BNT162b2 booster after 6-months of primary protocol.…”
  9. 57369

    Individual hippocampal CA1 pyramidal cells differed in their responses to Zolpidem. by Tamara Berdyyeva (654876)

    Published 2014
    “…<p><b>A</b>: Representative raster plot of calcium transients in individual cells (n = 195) that are color-coded depending on their response to Zolpidem (Mann-Whitney-Wilcoxon test, p<0.05 criterion of significance): significant decrease (blue); significant increase (red), non-significant change (black). …”
  10. 57370

    Improvement of Colloidal Characteristics in a Precursor Solution by a PbI<sub>2</sub>‑(DMSO)<sub>2</sub> Complex for Efficient Nonstoichiometrically Prepared CsPbI<sub>2.8</sub>Br<... by Hang Zhao (143592)

    Published 2020
    “…The optimized film exhibits a clearly improved crystallinity and a decrease in defect concentration from 4.29 × 10<sup>15</sup> cm<sup>–3</sup> to 3.20 × 10<sup>15</sup> cm<sup>–3</sup>. …”
  11. 57371

    Improvement of Colloidal Characteristics in a Precursor Solution by a PbI<sub>2</sub>‑(DMSO)<sub>2</sub> Complex for Efficient Nonstoichiometrically Prepared CsPbI<sub>2.8</sub>Br<... by Hang Zhao (143592)

    Published 2020
    “…The optimized film exhibits a clearly improved crystallinity and a decrease in defect concentration from 4.29 × 10<sup>15</sup> cm<sup>–3</sup> to 3.20 × 10<sup>15</sup> cm<sup>–3</sup>. …”
  12. 57372

    Improvement of Colloidal Characteristics in a Precursor Solution by a PbI<sub>2</sub>‑(DMSO)<sub>2</sub> Complex for Efficient Nonstoichiometrically Prepared CsPbI<sub>2.8</sub>Br<... by Hang Zhao (143592)

    Published 2020
    “…The optimized film exhibits a clearly improved crystallinity and a decrease in defect concentration from 4.29 × 10<sup>15</sup> cm<sup>–3</sup> to 3.20 × 10<sup>15</sup> cm<sup>–3</sup>. …”
  13. 57373

    Intervention description. by Ayele Semachew Kasa (8808809)

    Published 2024
    “…Residents of Ethiopia, ≥60 years and living in the community will be invited to participate in a 24-week program designed to decrease frailty and associated health consequences. …”
  14. 57374

    Image_1_Development of a Quantitative Assay for the Characterization of Human Collectin-11 (CL-11, CL-K1).TIF by Rafael Bayarri-Olmos (695469)

    Published 2018
    “…Furthermore, we observed a significant decrease at admission in CL-11 plasma levels in patients admitted to intensive care with systemic inflammatory response syndrome. …”
  15. 57375
  16. 57376

    ASL transcript associates with AtRRP6L1 protein and H3K27 trimethylated regions and <i>rrp6l1/2</i> mutants have decreased H3K27me3 and nucleosome density. by Jun-Hye Shin (395757)

    Published 2014
    “…<p>(A) ASL transcript directly associates with AtRRP6L1 protein and H3K27me3 regions of <i>FLC</i>. …”
  17. 57377

    Data_Sheet_1_Association of folate and vitamin B12 imbalance with adverse pregnancy outcomes among 11,549 pregnant women: An observational cohort study.doc by Xiaosong Yuan (6683027)

    Published 2022
    “…A higher SFVB12R increased birthweight (β 60.99; 95% CI 29.52–92.45) and was associated with a higher risk of large-for-gestational-age (LGA) newborns (OR 3.08; 95% CI 1.63–5.83); a lower SFVB12R decreased birthweight (β −43.81; 95% CI −75.62, −12.00) and was associated with a lower risk of LGA newborns (OR 0.75; 95% CI 0.56–1.00), and with higher risks of ICP (OR 2.03; 95% CI 1.54–2.67) and pregnancy-induced hypertension (PIH, OR 1.81; 95% CI 1.09–3.00).…”
  18. 57378
  19. 57379
  20. 57380

    Illustrative example of a simulation on the evolution of protein denaturation temperature under threshold selection for both thermodynamic stability and kinetic stability. by M. Luisa Romero-Romero (347004)

    Published 2016
    “…(C) The mutations that decrease the unfolding rate, also decrease the unfolding equilibrium constant which, as a result, falls order of magnitude low the (assumed constant in this simulation) K* threshold; (D) The decrease in unfolding equilibrium constant is reflected in an increase in equilibrium denaturation temperature, as expected from the van’t Hoff equation and the endothermic character of protein unfolding. …”